{{knowledge objective
|Identifiant=OIC-243-10-A
|Item_parent=Hypothyroidism
|Item_parent_short=Hypothyroidism
|Rank=A
|Title=Knowing the principle of hormone replacement therapy in hypothyroidism
|Description=None
|Rubric=Management
|Contributors=Eva Feigerlova,Igor Tauveron,Stéphanie Espiard
|Order=10}}

'''1. means and objectives [[Principle of proper use of medicines and non-medicinal|therapeutic therapies]]  [[Follow-up consultation and therapeutic education for a patient with hypothyroidism SD-284]]''''

Treatment is based on the use of marketed T4.

Thyroid hormone requirements average 1 to 1.5 µg/kg per day.


A. Primary hypothyroidism

- Therapeutic balance is based on TSH monitoring: this is carried out 6 to 8 weeks after the start or modification of treatment and then every 6 months to 1 year.


'''B. Thyrotropic insufficiency''''

- therapeutic balance is based on monitoring T4L levels

<ref>Polycopy of the Collège des Enseignants d'Endocrinologie, Diabète et Maladies Métaboliques (4th edition, 2019)</ref>
<references />